Business Description
Q32 Bio Inc
NAICS : 541714
SIC : 2833
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5.42 | |||||
Equity-to-Asset | 0.27 | |||||
Debt-to-Equity | 0.59 | |||||
Debt-to-EBITDA | -0.3 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 1.05 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.72 | |||||
9-Day RSI | 55.75 | |||||
14-Day RSI | 55.57 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.49 | |||||
Quick Ratio | 6.49 | |||||
Cash Ratio | 6.26 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -5.31 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 518.39 | |||||
Net Margin % | 445.58 | |||||
FCF Margin % | 247.39 | |||||
ROA % | -60.47 | |||||
ROIC % | -174.44 | |||||
ROC (Joel Greenblatt) % | -834.44 | |||||
ROCE % | -110.03 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 18.11 | |||||
Price-to-Tangible-Book | 18.17 | |||||
EV-to-EBIT | -7.87 | |||||
EV-to-EBITDA | -7.93 | |||||
EV-to-Revenue | -40.8 | |||||
EV-to-FCF | -16.54 | |||||
Price-to-Net-Current-Asset-Value | 29.07 | |||||
Price-to-Net-Cash | 35.74 | |||||
Earnings Yield (Greenblatt) % | -12.71 | |||||
FCF Yield % | -5.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Q32 Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | -11.703 | ||
EPS (TTM) (€) | -2.342 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 55.57 | ||
14-Day ATR (€) | 1.599735 | ||
20-Day SMA (€) | 41.74 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (€) | 31.2 - 45.6 | ||
Shares Outstanding (Mil) | 12.06 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Q32 Bio Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Q32 Bio Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Q32 Bio Inc Frequently Asked Questions
What is Q32 Bio Inc(STU:DB0)'s stock price today?
When is next earnings date of Q32 Bio Inc(STU:DB0)?
Does Q32 Bio Inc(STU:DB0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |